It was shown that tumor cells extracted from different types of leukemia/lymphoma expressed heterogeneous levels of NKG2DL which rendered them susceptible to NK cell-mediated lysis in an NKG2D-dependent manner [8], [21]. This evidence concerns the gene KLRK1 and neoplasm.